|
FY2022
12 months to Mar 31, 2022
|
FY2021
12 months to Mar 31, 2021
|
FY2020
12 months to Mar 31, 2020
|
FY2019
12 months to Mar 31, 2019
|
FY2018
12 months to Mar 31, 2018
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative (including $507,000 and $517,000 of related party legal expenses, respectively) | |||||
| Severance expense | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Change in fair value of warrant liability | |||||
| Gain on warrant exchange | |||||
| Interest income | |||||
| Other income | |||||
| Interest expense | |||||
| Total other income (expense) | |||||
| Loss before income taxes | |||||
| Net loss | |||||
| Other comprehensive loss | |||||
| Unrealized loss on marketable securities, net of tax | |||||
| Comprehensive loss | |||||
| Basic and diluted loss per common share | |||||
| Basic and diluted weighted average shares outstanding | |||||
Loading...